Can tamoxifen (Tamoxifen) cause leukopenia (low white blood cell count)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Tamoxifen can cause leukopenia, although it is not explicitly mentioned in the provided study as a common side effect. The study 1 focuses on the toxicity experience in women enrolled in the NSABP Breast Cancer Prevention Trial, and it does not directly report leukopenia as a side effect. However, it does discuss other toxicities such as invasive endometrial cancer, deep vein thrombosis, stroke, pulmonary embolism, bone fracture, ischemic heart disease, and cataracts. Some key points to consider when evaluating the potential for tamoxifen to cause leukopenia include:

  • The mechanism of action of tamoxifen as a selective estrogen receptor modulator
  • The potential for bone marrow suppression, which could lead to leukopenia
  • The importance of monitoring complete blood counts in patients taking tamoxifen
  • The need for patients to report symptoms such as fever, chills, or recurrent infections, which could indicate compromised immune function due to low white blood cell counts Given the potential for tamoxifen to cause leukopenia, healthcare providers should monitor patients taking this medication for signs of decreased white blood cell count and adjust treatment as necessary.

From the FDA Drug Label

Leukopenia has been observed, sometimes in association with anemia and/or thrombocytopenia. There have been rare reports of neutropenia and pancytopenia in patients receiving tamoxifen; this can sometimes be severe.

Yes, tamoxifen can cause leukopenia, as stated in the drug label 2 and 2. This is also associated with other conditions such as anemia and thrombocytopenia. Additionally, there have been rare reports of neutropenia and pancytopenia in patients taking tamoxifen.

From the Research

Tamoxifen and Leukopenia

  • There is limited direct evidence on tamoxifen causing leukopenia, but some studies suggest that tamoxifen can cause blood-related side effects, including thrombocytopenia 3, 4.
  • A study reported two cases of acute myeloid leukemia (AML) during tamoxifen therapy for breast cancer, suggesting a possible link between tamoxifen and leukemia 5.
  • However, the studies provided do not specifically mention leukopenia as a side effect of tamoxifen.
  • The available evidence suggests that tamoxifen can cause various side effects, including thrombocytopenia and potentially leukemia, but the relationship between tamoxifen and leukopenia is not well-established 3, 4, 5, 6, 7.

Related Side Effects

  • Thrombocytopenia is a rare side effect of tamoxifen, with some studies reporting cases of thrombocytopenia in patients taking tamoxifen 3, 4.
  • Tamoxifen has been associated with an increased risk of secondary cancers, including leukemia 5.
  • The studies provided do not mention leukopenia as a specific side effect of tamoxifen, but they do suggest that tamoxifen can cause blood-related side effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Tamoxifen induced-thrombocytopenia: it does occur.

Medical oncology (Northwood, London, England), 2007

Research

Tamoxifen-induced thrombocytopenia.

American journal of clinical oncology, 1999

Research

Acute leukaemia during tamoxifen therapy.

Medical oncology (Northwood, London, England), 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.